Healthcare and Medical Device

The global clinical communication and collaboration market is projected to grow rapidly from $2.6 billion in 2024 to $4.8 billion by 2029, at a compound annual growth rate (CAGR) of 13.2%. This growth is driven by several key factors, including the advantages of these solutions in enhancing patient care and safety, the significant demand for cost-containment solutions within healthcare delivery systems, the rising geriatric population, and the growing adoption of big data and mHealth tools. Clinical communication solutions enable seamless flow of real-time health data, enabling constant patient monitoring, minimizing errors, and ensuring timely interventions, ultimately enhancing patient safety and care quality. However, the high investments required to build and maintain robust IT infrastructure pose a significant restraint for some healthcare providers, particularly smaller clinics with limited budgets. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.as...

The global enteral feeding devices market is witnessing rapid growth driven by the increasing prevalence of chronic diseases, especially among the aging population. Valued at $4.0 billion in 2023, this market is projected to reach $5.6 billion by 2029, expanding at a robust compound annual growth rate (CAGR) of 6.2%. Enteral feeding devices offer a reliable solution for delivering essential nutrients to patients who cannot consume sufficient food orally due to conditions such as swallowing difficulties, appetite loss, or medical treatments like surgery, radiation therapy, or chemotherapy. These devices are transforming the healthcare industry, providing significant advantages for manufacturers and patients alike. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035 The Rising Demand for Enteral Feeding The global rise in chronic diseases, coupled with the growing elderly population, is a major driving force behind the increasing demand for...

The global oligonucleotide synthesis market is booming, projected to grow from $8.8 billion in 2024 to a staggering $19.7 billion by 2029 at a compound annual growth rate (CAGR) of 17.5%. This meteoric rise is fueled by several key drivers and emerging opportunities in the industry. A major catalyst is the increasing use of synthesized oligonucleotides in therapeutic and diagnostic applications. Oligonucleotide-based drugs hold immense potential for treating a wide range of neurological and rare diseases, leading to a surge in regulatory approvals. Additionally, oligonucleotides play a crucial role in genetic testing, molecular diagnostics, microarrays, and gene therapy, driving demand for accurate and sensitive detection and quantification tools. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350 While the market is thriving, it faces challenges, such as complexities associated with controlling oligonucleotide length and minimizing impuri...

The global healthcare analytical testing services market is poised for remarkable growth in the coming years, driven by a multitude of factors shaping the industry landscape. According to a comprehensive market analysis, this sector is projected to reach a staggering $12.6 billion by 2029, expanding at an impressive compound annual growth rate (CAGR) of 11.2% from its estimated value of $7.4 billion in 2024. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=108923833 This burgeoning market is fueled by the increasing demand for quality assurance and regulatory compliance across industries. As healthcare organizations strive to develop precise analytical techniques, service providers are presented with lucrative opportunities to cater to these evolving needs. Moreover, supportive government initiatives and rising investments in research and innovation further propel the market's growth trajectory. At the forefront of this growth lies the bioheal...

The global home healthcare market is poised to achieve significant growth, expected to soar to USD 383.0 Billion by 2028 from USD 250.0 Billion in 2023, indicating a robust CAGR of 8.9% during the forecast period. This growth trajectory is primarily propelled by the expanding elderly population and the increasing prevalence of chronic ailments. Key Market Players: Leading players in the market include Fresenius SE & Co. KGaA (Germany), Abbott (US), GE HealthCare (US), Koninklijke Philips N.V. (Netherlands), ResMed, Inc. (US), among others. These key industry participants are strategically employing various tactics to steer the global growth trajectory of the home healthcare sector. Download a PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=696 Fresenius SE & Co. KGaA (Germany): Fresenius SE & Co. KGaA (Germany) secured the top position in the home healthcare market in 2022, commanding a 4.7% market share. The company has cemented its leading...